{"count": 2, "results": [{"_id": "36598818", "pmid": 36598818, "pmcid": "PMC9812404", "title": "Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals", "journal": "Elife", "authors": ["Xu L", "Zhang X", "Zhao Y", "Gang X", "Zhou T", "Han J", "Cao Y", "Qi B", "Song S", "Wang X", "Liang Y"], "date": "2023-01-04T00:00:00Z", "doi": "10.7554/eLife.81198", "meta_date_publication": "2023 Jan 4", "meta_volume": "12", "meta_issue": "", "meta_pages": "", "score": 50266.535, "text_hl": "@<m>DISEASE_Ocular_Hypertension</m> @DISEASE_MESH:D009798 @@@Ocular hypertension@@@ (@<m>DISEASE_Ocular_Hypertension</m> @DISEASE_MESH:D009798 @@@OHT@@@) @SPECIES_10090 @@@mouse@@@ models were induced with @CHEMICAL_Dexamethasone @CHEMICAL_MESH:D003907 @@@dexamethasone@@@ and further treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to determine the intraocular pressure (IOP)-lowering effect. ", "citations": {"NLM": "Xu L, Zhang X, Zhao Y, Gang X, Zhou T, Han J, Cao Y, Qi B, Song S, Wang X, Liang Y. Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals Elife. 2023 Jan 4;12():. PMID: 36598818", "BibTeX": "@article{36598818, title={Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals}, author={Xu L and Zhang X and Zhao Y and Gang X and Zhou T and Han J and Cao Y and Qi B and Song S and Wang X and Liang Y}, journal={Elife}, volume={12}}"}}, {"_id": "39182626", "pmid": 39182626, "title": "Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.", "journal": "Ophthalmology", "authors": ["Muayad J", "Loya A", "Hussain ZS", "Chauhan MZ", "Alsoudi AF", "De Francesco T", "Ike K Ahmed I"], "date": "2024-08-23T00:00:00Z", "doi": "10.1016/j.ophtha.2024.08.023", "meta_date_publication": "2024 Aug 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.805, "text_hl": "CONCLUSIONS: GLP-1 receptor agonists are associated with a significantly lower incidence of @DISEASE_Glaucoma_Open_Angle @DISEASE_MESH:D005902 @@@POAG@@@, @<m>DISEASE_Ocular_Hypertension</m> @DISEASE_MESH:D009798 @@@ocular hypertension@@@, and the need for first-line @DISEASE_Glaucoma @DISEASE_MESH:D005901 @@@glaucoma@@@ treatments compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@. ", "citations": {"NLM": "Muayad J, Loya A, Hussain ZS, Chauhan MZ, Alsoudi AF, De Francesco T, Ike K Ahmed I. Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients. Ophthalmology. 2024 Aug 23;():. PMID: 39182626", "BibTeX": "@article{39182626, title={Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.}, author={Muayad J and Loya A and Hussain ZS and Chauhan MZ and Alsoudi AF and De Francesco T and Ike K Ahmed I}, journal={Ophthalmology}}"}}]}